Hospital
Catholic Health Initiatives Colorado
Catholic Health Initiatives Colorado was paid $8.91M by Medicaid between Jan 2018 and Dec 2024, across 89 billing codes. Its largest line is 99283, emergency room visit (moderate) — 32% of everything it billed.
33Billing provider infoCATHOLIC HEALTH INITIATIVES COLORADO
LAKEWOOD, CO 80228
LAKEWOOD, CO 80228
33aNPI1164430567assigned 08/03/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$8.91M
24GClaims227,300
24DCodes billed89
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Colorado
Rank by total paid#16 of 51
Median peer was paid$1.24M
This provider vs. median7.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RICHERT, TADD controls 16+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 33,829 | $916K | |
| 2019 | 22,803 | $838K | |
| 2020 | 21,087 | $843K | |
| 2021 | 24,499 | $1.01M | |
| 2022 | 30,544 | $1.54M | |
| 2023 | 48,805 | $1.89M | |
| 2024incomplete | 45,733 | $1.88M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 32% | 24,145 | 22,012 | $2.84M |
| 96361 | Intravenous infusion, hydration; each additional hour | 14% | 4,923 | 4,158 | $1.24M |
| 64483 | 13% | 1,921 | 1,738 | $1.13M | |
| 64493 | 7.6% | 936 | 783 | $679K | |
| 64490 | 4.6% | 579 | 504 | $410K | |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.1% | 3,401 | 3,015 | $369K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3.5% | 2,498 | 2,325 | $310K |
| 62321 | 2.6% | 532 | 501 | $232K | |
| G0260 | Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography | 2.6% | 1,571 | 786 | $229K |
| G0378 | Hospital observation service, per hour | 1.7% | 4,372 | 1,931 | $152K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.7% | 1,605 | 1,383 | $149K |
| 64635 | 1.6% | 257 | 202 | $141K |
77 more codes
| 80053 | Comprehensive metabolic panel | 1.5% | 12,540 | $132K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.4% | 7,908 | $122K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.3% | 628 | $112K |
| 99285 | Emergency room visit (most serious) | 1.2% | 1,113 | $109K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.2% | 796 | $108K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,119 | $83K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 895 | $65K |
| 96401 | <1% | 160 | $39K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 184 | $33K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 156 | $27K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 12,038 | $24K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 273 | $23K |
| 84484 | <1% | 2,066 | $22K | |
| J2357 | Injection, omalizumab, 5 mg | <1% | 14 | $16K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 72 | $12K |
| 97597 | <1% | 609 | $10K | |
| 64479 | <1% | 12 | $10K | |
| 64633 | <1% | 16 | $9K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 37,294 | $7K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 96 | $7K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 15,986 | $7K |
| 83605 | <1% | 356 | $7K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 40 | $7K |
| 0002A | <1% | 101 | $6K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,390 | $6K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 7,446 | $5K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 58 | $5K |
| 0001A | <1% | 91 | $4K | |
| 80320 | <1% | 27 | $3K | |
| 73610 | <1% | 164 | $3K | |
| J2800 | Injection, methocarbamol, up to 10 ml | <1% | 451 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,058 | $2K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 39 | $1K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 15 | $1K |
| 87400 | <1% | 34 | $942.64 | |
| 87040 | <1% | 38 | $940.64 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 29 | $917.74 |
| 71045 | Radiologic examination, chest; single view | <1% | 1,316 | $878.34 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,651 | $824.12 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 27 | $641.89 |
| 85027 | <1% | 1,254 | $452.01 | |
| 64636 | <1% | 460 | $366.11 | |
| 64634 | <1% | 41 | $366.11 | |
| 85379 | <1% | 43 | $358.72 | |
| 83690 | <1% | 974 | $276.80 | |
| 81001 | <1% | 823 | $177.50 | |
| 64494 | <1% | 809 | $162.61 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 7,702 | $111.94 |
| 82077 | <1% | 179 | $65.04 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 16 | $41.38 |
| 84703 | <1% | 159 | $36.21 | |
| 99152 | <1% | 813 | $20.74 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 620 | $14.99 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 4,515 | $4.93 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 6,164 | $2.71 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 14 | $0.00 |
| J3490 | Unclassified drugs | 0% | 31,138 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 2,697 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 2,766 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 287 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 1,881 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 4,312 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 360 | $0.00 |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 18 | $0.00 |
| 96376 | 0% | 327 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 38 | $0.00 |
| 64492 | 0% | 22 | $0.00 | |
| 64484 | 0% | 53 | $0.00 | |
| 64491 | 0% | 695 | $0.00 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 0% | 75 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 60 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 754 | $0.00 |
| 81003 | 0% | 26 | $0.00 | |
| 71046 | Radiologic examination, chest; 2 views | 0% | 112 | $0.00 |
| 64495 | 0% | 20 | $0.00 | |
| 87634 | 0% | 14 | $0.00 | |
| 82248 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRICHERT, TADD (CFO)
Parent organizationCATHOLIC HEALTH INITIATIVES
| Provider | Location | Paid |
|---|---|---|
| Catholic Health Initiatives Colorado | Colorado Springs, CO | $25.26M |
| Catholic Health Initiatives Colorado | Pueblo, CO | $23.66M |
| Catholic Health Initiatives Colorado | Canon City, CO | $8.35M |
| Catholic Health Iniatives Colorado | Westminster, CO | $7.55M |
| Catholic Health Initiatives Colorado | Canon City, CO | $6.39M |
| Catholic Health Initiatives Colorado | Durango, CO | $5.98M |
| Longmont United Hospital | Longmont, CO | $5.25M |
| Catholic Health Initiatives Colorado | Lakewood, CO | $4.40M |
| Commonspirit Kansas, INC. | Ulysses, KS | $2.77M |
| Commonspirit Kansas, INC. | Garden City, KS | $1.22M |
| Catholic Health Initiatives Colorado | Fort Morgan, CO | $1.17M |
| Catholic Health Iniatives Colorado | Frisco, CO | $691K |
| ST. Vincent Infirmary Medical Center | Sherwood, AR | $469K |
| Commonspirit Kansas, INC. | Dodge City, KS | $267K |
| Catholic Health Initiatives Colorado | Pueblo, CO | $153K |
| Catholic Health Initiatives Colorado | Colorado Springs, CO | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.